What is Aqemia?
Aqemia is revolutionizing the pharmaceutical industry as a cutting-edge pharmatech company that originated as a deeptech spin-off from École normale supérieure. Unlike conventional AI platforms that rely on experimental data for training, Aqemia utilizes proprietary quantum physics algorithms developed through 12 years of research at Oxford, Cambridge, and ENS/CNRS to generate its own data.
The company has rapidly expanded to a team of over 50 professionals, establishing collaborations with major pharmaceutical companies while developing its own drug discovery pipeline. Their quantum-inspired physics approach, combined with generative AI, enables them to identify innovative drug candidates at unprecedented speeds - 10,000 times faster than traditional methods.
Features
- Quantum-Inspired Physics: Proprietary algorithms developed through 12 years of research
- Data Generation: Self-generates training data without requiring experimental input
- Speed Enhancement: 10,000x faster than traditional drug discovery methods
- AI Integration: Combines physics with generative AI for drug candidate discovery
- Pipeline Development: Manages multiple projects from hit generation to vivo assays
Use Cases
- Drug candidate discovery and development
- Early-stage drug discovery projects
- Pharmaceutical research acceleration
- Drug pipeline development
- Biotech spin-off creation
FAQs
-
How does Aqemia differ from traditional AI-based drug discovery platforms?
Unlike traditional platforms that need experimental data for training, Aqemia generates its own data using quantum physics algorithms, making it self-sufficient and faster in drug discovery processes. -
How much faster is Aqemia compared to traditional methods?
Aqemia operates 10,000 times faster than traditional drug discovery methods thanks to its unique quantum-inspired physics algorithms. -
What is the background of Aqemia's technology?
Aqemia's technology is based on 12 years of research conducted at prestigious institutions including Oxford, Cambridge, and ENS/CNRS.
